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Translationally controlled tumor protein (TCTP) expression is suppressed during cancer cell rever-
sion to a non-malignant phenotype. We identiﬁed a primary sequence of TCTP with homology to
ADF/coﬁlin. We conﬁrm that a synthetic peptide corresponding to this sequence binds speciﬁcally
to actin and is displaced from actin by coﬁlin. TCTP peptide has higher afﬁnity for G-actin than F-
actin and does not block actin-ﬁlament depolymerization by coﬁlin. These results suggest that TCTP
may channel active coﬁlin to F-actin, enhancing the coﬁlin-activity cycle in invasive tumor cells.
Loss of TCTP may result in sequestration of active coﬁlin by a monomeric pool of actin.
Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction mary tumor cells [11,12]. Coﬁlin binds to both monomeric and ﬁl-Translationally controlled tumor protein (TCTP) is a highly con-
served protein that is involved in cell cycle regulation and tumor
reversion [1]. This protein is highly expressed in cells actively
dividing by mitosis [2] and contributes to the progression of cancer
[1]. Inhibition of TCTP expression by siRNA leads to tumor rever-
sion and dramatic changes in the cell morphology of malignant
ﬁbroblasts [3], while breast cancer cells subjected to similar treat-
ment reorganize into normal, non-cancerous growth pattern [4].
TCTP localizes in regions of abundant actin at the cortical margin
of migrating XL2 cells and at cytochalasin-D induced foci of
actin-monomers [5]. A direct interaction of TCTP and actin may
explain reorganization of cytoskeleton following TCTP
downregulation.
Examination of the primary sequence of TCTP reveals homology
to the actin-binding region of coﬁlin. Coﬁlin is implicated in che-
motaxis [6,7] and cell growth [8] and is believed to promote tumor
metastatis by enhancing actin dynamics at the leading cell edge
[9]. Elevated levels of active, dephosphorylated coﬁlin are
correlated with high invasiveness of neuroblastoma [10] and mam-lf of the Federation of European Bi
or protein; NHS, N-hydrox-
ylaminopropyl]carbodiimide;
arboxytetramethylrhodamine
r Rd., University of Florida,
ubb).amentous actin, but its main effect on actin dynamics is binding to
and changing the twist of the actin ﬁlament [13] which may result
in ﬁlament severing and/or increases in the rate of depolymeriza-
tion of ADP-actin subunits from the pointed actin ﬁlament end
[14,15].
2. Materials and methods
2.1. Proteins and peptides
Rabbit skeletal muscle actin was puriﬁed and labeled with pyr-
ene iodoacetamide as described in [16]. Mg2+-G-actin was pre-
pared from Ca2+-G-actin in G-buffer (5 mM Tris, 0.1 mM CaCl2,
1% sodium azide, 0.2 mM ATP, 0.2 mM DTT, pH 7.9) by addition
of 0.125 mM EGTA and 0.05 mM MgCl2. ATP- and ADP-G-actin
solutions were prepared as described in [16]. Lyophilized recombi-
nant coﬁlin was purchased from Cytoskeleton, Inc. (Denver, Colo-
rado). Recombinant TCTP protein stock (1 mg/mL in 0.10 M
sodium phosphate, pH 8) was prepared as in [17]. Synthesis of
the peptides corresponding to TCTP residues 75-NHHLQETSFT-
KEAYKKYIKDYMKSIK-97 was accomplished by the Chemistry and
Biomarkers Core Facility, University of Florida. To label the peptide,
the C-terminal Lys was epsilon-amino modiﬁed with 5(6)-carboxy-
tetramethylrhodamine succinimidyl ester during synthesis. Both
unlabeled (MW 3231.75 Da) and labeled (MW 3644.24 Da) TCTP
peptides were HPLC puriﬁed, and characterized by mass
spectroscopy.ochemical Societies.
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Fluorescence anisotropy data were obtained using a PTI spec-
troﬂuorometer (South Brunswick, NJ, USA) as described in [16],
including negative controls using peptides with no apparent afﬁn-
ity to G- or F-actin. Direct binding data for samples containing
0.1 lM rhodamine-labeled TCTP peptide (rh-TCTP) contained vary-
ing concentrations of Mg2+-G-actin. After measurements, 2 mM
MgCl2 and 40 mM KCl were added into each sample and the sam-
ples were incubated at room temperature for 24 h followed by
anisotropy measurements. For direct binding to Mg2+-ADP-G-actin,
rh-TCTP peptide (0.15 lM) was assayed in 2 mMMgCl2 and 40 mM
KCl prior to polymerization. Steady-state data were obtained with
3 lM Ca2+-G-actin or 3 lMMg2+-F-actin samples to which peptide
was added after polymerization had reached steady-state.
2.3. High-speed pelleting assay and the time course of actin
polymerization
Four percent pyrene-labeled 3 lMMg2+-G-actin (in the pres-
ence of 0, 5, or 15 lM unlabeled or rh-TCTP peptide) was polymer-
ized with 2 mM MgCl2 and 40 mM KCl at room temperature.
Pyrene ﬂuorescence of the samples was recorded and F-actin was
pelleted by centrifugation at 140 000g at 12 C for 1 h. After mea-
suring the pyrene ﬂuorescence of the supernatants, both pellets
and supernatants were analyzed by SDS–PAGE. Time course of
polymerization data were obtained by following actin pyrene ﬂuo-
rescence immediately after the addition of MgCl2 and KCl with and
without rh-TCTP peptide.
2.4. Covalent cross-linking with 1-ethyl-3-
[3-dimethylaminopropyl]carbodiimide (EDC)
Actin in G-buffer was combined with rh-TCTP peptide or pep-
tide buffer. Cross-linking solution was added after initiation of ac-
tin polymerization or after polymerization had reached steady
state. Cross-linking solution was freshly prepared as an intermedi-
ate aqueous N-hydroxysulfosuccinimide (NHS) dilution, with sub-
sequent dilution to ﬁnal concentrations at a molar ratio of 5:2;
NHS–EDC. Cross-linking was quenched after 15 min at room tem-
perature with SDS–PAGE sample buffer. A control experiment with
10 lM BSA in place of actin (EDC varied from 0 to 8 mM) was per-
formed in G-buffer.
Actin polymerization induced by EDC and NHS was monitored
by the ﬂuorescence of pyrene-labeled actin. After EDC addition,
60 lL of each sample was transferred from glass cuvette into a cen-
trifuge tube, and F-actin was pelleted at 140 000g at 8 C for
30 min. This experiment was replicated with unlabeled actin by
preparing samples directly in centrifuge tubes. Supernatants and
pellets were analyzed by SDS–PAGE.3. Results
3.1. Analysis of the sequence of TCTP provides a rationale for design of
a TCTP peptide
Preliminary experiments with recombinant TCTP conﬁrmed
prior published cell biological evidence that TCTP interacted with
the actin cytoskeleton [5], showing a concentration-dependent
increase in steady-state actin pyrenyl-actin ﬂuorescence with
increasing TCTP (Supplementary Fig. 1A), but no deﬁnite change
in the polymerization of actin at steady state using high-speed pel-
leting (data not shown). Speculating that the interaction between
TCTP and actin could be regulated by divalent cations or post-
translational modiﬁcations, so that full biologic activity is not ob-served in recombinant TCTP, we examined available structural data
for TCTP [18]. A comparison of the primary sequences of TCTP and
ADF/coﬁlin led to the identiﬁcation of a region of homology be-
tween TCTP and G-actin binding-site of coﬁlin [19,20] (Fig. 1). This
region of TCTP spans major portions of the short and long helices
[17,21]. The corresponding sequence of coﬁlin is found in the C-
terminal portion of the long, bent helix [20]. The primary se-
quences of the aligned regions contain 20 conserved residues
(54% conserved; 16% identity), including many previously identi-
ﬁed as important for coﬁlin-actin interactions, and these residues
map to the surface of TCTP. Based on this sequence alignment, a
TCTP peptide was synthesized for further assays.
3.2. TCTP peptide binds preferentially to G-actin than to F-actin
Both unlabeled and rh-TCTP peptides cause a change in ﬂuores-
cence of pyrene-labeled Ca2+-G-actin in a concentration-dependent
manner, providing qualitative evidence of binding to G-actin. The
ﬂuorescence increase produced by the unlabeled peptide (50%)
is in the opposite direction as the decrease associated with the rho-
damine-labeled peptide (65%; Supplementary Fig. 1B). These
changes presumably reﬂect interactions that alter the local envi-
ronment of pyrene, and, not surprisingly, are different when a pep-
tide with a large, hydrophobic rhodamine derivative binds in
comparison to binding of unlabeled peptide alone. The close prox-
imity of TCTP to the pyrene ﬂuorophore attached to Cys376 of actin
is in agreement with the reported structure of coﬁlin-actin inter-
face [19,20].
An anisotropy assay of the rhodamine label on TCTP peptide
provides a quantitative assessment of binding. The anisotropy of
rh-TCTP peptide increases with ATP-Mg2+-G-actin concentration
(Fig. 2A), and a binding curve representing a ﬁt to these data
(assuming one-to-one complex) yields a Kd of 2.4 lM. Note that
this Kd is similar to that reported for binding of G-actin to coﬁlin
(2–8 lM) and is especially remarkable given that peptides corre-
sponding to actin-binding sequences generally are of very low
afﬁnity (>100 lM) [14,22,23]. When MgCl2 and KCl are added to
the same samples to polymerize actin to steady state, the anisot-
ropy of the peptide at saturation by actin decreases, and the appar-
ent Kd increases to 35 lM. When Mg2+-G-actin is combined with
both rh-TCTP peptide and excess coﬁlin, anisotropy remains at
the control level, suggesting competition between the peptide
and coﬁlin for binding to actin (Fig. 2B). Direct binding assays using
ﬂuorescence intensity (Kd of 0.10 lM) or anisotropy (Kd of
0.13 lM) show that the TCTP peptide binds with higher afﬁnity
to ADP-G-actin than to ATP-G-actin (Fig. 2C). Again this is similar
to coﬁlin, which binds to ADP-G-actin with Kd of 0.3 lM [23]. How-
ever, unlike coﬁlin, there is no evidence for increased afﬁnity to
ADP-F-actin, as demonstrated in Fig. 2A and by the failure of rh-
TCTP to co-pellet with actin in a high speed F-actin pelleting assay
(F-actin at steady-state is predominantly ADP-F-actin).
Actin depolymerization assays demonstrate no effect of 20 lM
rh-TCTP peptide on the actin depolymerization rate or on the
acceleration of depolymerization by 0.6 lM coﬁlin (data not
shown). These results suggest that, unlike coﬁlin, TCTP peptide
by itself is unable to generate sufﬁcient structural change in F-actin
to accelerate depolymerization, and that at these concentrations
TCTP is unable to block access to F-actin by coﬁlin.
3.3. TCTP peptide does not alter F-actin concentration at steady state
The presence of unlabeled or rh-TCTP peptide decreases the
ﬂuorescence of pyrenyl-F-actin during polymerization; the effect
of rh-TCTP peptide being more potent (inset to Fig. 3C). However,
when samples are allowed to reach steady state, a corresponding
increase in unpolymerized actin is not conﬁrmed by high-speed
Fig. 1. Sequence alignment of human coﬁlin, ADF, and TCTP (top). Conserved residues are highlighted in green. Coﬁlin residues known to contribute to binding to actin are
marked with asterisks and underlined portions are helical. The TCTP sequence corresponding to the synthetic peptide evaluated here is shown in blue in both the primary
sequence and the structure of TCTP (PDB accession number 2HR9). Coﬁlin-homology in TCTP is well conserved in mammalian species, with only a single substitution, Leu93
for Ile93, in both mouse and rat (bottom).
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measurements after addition of peptide to ﬁlamentous actin,
which then show similar pyrenyl-F-actin ﬂuorescence in presence
or absence of the peptides (Supplementary Fig. 1B). Moreover, as
mentioned above, TCTP did not alter the apparent subunit dissoci-
ation rate during depolymerization, again consistent with an
absence of effect on actin ﬁlament structure. The simplest interpre-
tation of these results is that the TCTP peptide slows the time
course of polymerization by an effect independent of steady-state
effects, that is, an effect on nucleation. This does not imply that
steady-state effects are absent, only that they are unobservable be-
cause of a lack of net change in ﬁlamentous actin. For example,
TCTP may stabilize actin ﬁlaments leading to a decrease in the free
actin concentration at steady state (the critical concentration) and
a corresponding increase in unpolymerized actin by sequestration
in complex with TCTP, resulting in no apparent overall change in F-
actin concentration.
3.4. Covalent cross-linking of TCTP to actin
Covalent cross-linking with EDC produced a speciﬁc cross-link
of rh-TCTP peptide and actin monomer in high yield, particularly
when the reaction took place in G-buffer (Fig. 3A and B). The pep-
tide did not cross-link to BSA even in 8 mM EDC, conﬁrming the
speciﬁcity of the reaction (data not shown). The cross-link formedby EDC is zero-length peptide bond indicating close proximity be-
tween oppositely-charged residues and is considered to be indica-
tive of a salt-bridge interaction between interacting molecules
[22]. Here the yield is notably higher than that for cross-linking
of other actin-binding proteins, such as proﬁlin [19,22,24]. Since
TCTP has His at homologous positions to the Lys112 and Lys 114
of coﬁlin that cross-link to actin, the cross-linked residues between
TCTP peptide and actin are presumably different, and this may ac-
count for differences in cross-linking efﬁciency.
Cross-linked actin oligomers have been previously character-
ized, including a high electrophoretic mobility dimer that
corresponds to a non-ﬁlament antiparallel dimer and low electro-
phoretic mobility dimer that corresponds to a parallel dimer [25].
The parallel dimer, trimers and higher oligomers may represent
cross-linking that occurs within an actin ﬁlament or may represent
cross-linking of oligomers that have subunits in similar orientation
as intra-ﬁlament subunits. Comparing ﬂuorescent and non-ﬂuores-
cent images of the gel, TCTP peptide incorporation is visible in the
actin antiparallel dimer and trimer, but not into actin parallel di-
mer. The yield of the parallel dimer was lower in the presence of
TCTP peptide under all ionic conditions tested, whereas the yield
of actin trimer increased in the presence of peptide in samples
polymerized with MgCl2. These observations were also true if
EDC was added when actin polymerization had reached steady
state (Fig. 3A, lanes 9 and 10); therefore, the peptide did not have
Fig. 2. TCTP peptide binds to G-actin and competes with coﬁlin. (A) Binding curves
are obtained using the anisotropy assay. Solid lines represent the best ﬁt to a single-
site binding model for rh-TCTP peptide binding to ATP-G-actin (closed squares) and
F-actin at steady state (open squares). (B) Addition of 10 lM coﬁlin decreases the
anisotropy of 0.1 lM rh-TCTP peptide to the control level. Error bars ± S.D.; n = 8 (no
actin), n = 7 (5 lM actin), n = 6 (5 lM actin + 10 lM coﬁlin). (C) Assay of rh-TCTP
peptide binding to ADP-G-actin by change in ﬂuorescence intensity (closed squares)
and by anisotropy (open squares).
Fig. 3. TCTP peptide cross-links to G-actin and slows down actin polymerization.
5 mM EDC with 12.5 mM NHS is added to 10 lM actin alone or in the presence of
10 lM rh-TCTP peptide. Coomassie stained SDS gel (A) and rhodamine ﬂuorescence
(B) show the products of cross-linking. Lane 1, actin and peptide without EDC; lane
2, peptide with EDC; lanes 3 and 4, reaction in G-buffer; lanes 5 and 6, EDC added
immediately after 2 mM CaCl2; lanes 7 and 8, immediately after 2 mMMgCl2; lanes
9 and 10, at steady state in 2 mMMgCl2. TR = actin trimer, PD = parallel dimer, anti-
PD = antiparallel dimer, MA = monomeric actin, rhTp = rhodamine-TCTP peptide.
Overlay of the images in A and B shows that the TR and anti-PD band are
ﬂuorescent. (C) Fluorescence of 2.2 lM, 4% pyrenyl actin showing time course of
polymerization, with or without 8.6 lM rh-TCTP peptide, after addition of 2 mM
EDC and 5 mM NHS. Inset: time course of polymerization for 2.2 lM, 4% pyrenyl
actin with 2 mM MgCl2 and 40 mM KCl, with or without 8.6 lM rh-TCTP peptide.
(D) Less actin pellets in high speed centrifugation of samples from C after 25 min in
the presence of the peptide (lanes 2 and 4) than without (lanes 1 and 3).
Densitometry results for the actin bands were averaged from three gels, and are
depicted on the right with SD.
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effect on the cross-linking yields of actin oligomers. These results
suggest that TCTP interacts with actin oligomers, which could be
mechanistically related to the postulated inhibition of actin ﬁla-
ment nucleation.
Millimolar concentrations of EDC and NHS induced actin oligo-
merization without any additional salt. Cross-linking at lower EDC
concentration (2 mM) showed the same inhibitory effect of the
peptide on the amount of actin parallel dimer in G-buffer (data
not shown). After the addition of EDC and sulfo-NHS, the ﬂuores-
cence of pyrenyl actin increased very slowly, with a similar time
course to that obtained by polymerization in the presence of rh-
TCTP using Mg2+ and KCl (Fig. 3C). At a time when the polymeriza-
tion curves plus and minus rh-TCTP diverged signiﬁcantly,
centrifugation of samples to pellet F-actin showed that rh-TCTP
slowed, but did not completely inhibit, actin polymerization in-
duced by EDC and NHS (Fig. 3D). Thus, inhibition of polymerization
by TCTP peptide, suggested by loss of intra-ﬁlament parallel dimer
cross-linking, was conﬁrmed by the pelleting assay.
4. Discussion
Anisotropy and covalent cross-linking experiments with TCTP
peptide support the hypothesis that a TCTP sequence spanning
Asp75–Lys97 with homology to a G-actin binding site of coﬁlin
speciﬁcally binds to G-actin. Coﬁlin competes with this peptide
to bind to actin, as expected if both bind to the same site. Recom-binant TCTP and TCTP peptide had an effect on actin dynamics con-
sistent with inhibition of nucleation, and this was supported by
evidence of interaction with actin oligomers. Biological relevance
could be related to the fact the TCTP is abundant (nearly twice as
abundant as actin in growing cultures of Saccharomyces cerevisiae
[26]). TCTP is present at sufﬁcient concentration that it could reg-
ulate coﬁlin by displacing a stored pool of coﬁlin from G-actin. A
similar model of a coﬁlin-activity cycle [9] describes the need for
coﬁlin to be phosphorylated in order to be released from G-actin
in the cytosol, prior to activation and F-actin severing. Competition
between TCTP and coﬁlin could either support this mechanism or
offer an independent activation mechanism that enhances the coﬁ-
lin-activity cycle in invasive tumor cells. No matter what mecha-
nism utilized by tumor cells to activate actin dynamics, loss of
TCTP may induce tumor reversion by shutting down the pathway
for recycling actin ﬁlament subunits.
The relevance of augmented afﬁnity of TCTP to ADP-actin is un-
known. While there is speculation that coﬁlin complexes with
ADP-actin to form a storage pool of unpolymerized actin [23], there
is as yet no supportive evidence for the existence of such a pool of
ADP-actin. Expansion of this proposed ADP-actin pool with TCTP-
ADP-actin complex could potentially amplify actin dynamics,
assuming that this complex is also subject to activation by the
ubiquitous actin-binding protein Srv2/CAP [23].
Cross-linking by EDC suggests that TCTP peptide alters F-actin
structure, as we observe a consistent decrease in the amount of ac-
tin cross-linking as parallel dimer, but increase in trimer. Both of
4760 K. Tsarova et al. / FEBS Letters 584 (2010) 4756–4760these are intra-ﬁlament oligomers that result from cross-linking
subunits within F-actin [25]. A decrease in parallel dimer could
mean that TCTP peptide (1) decreases the amount of F-actin, (2) di-
rectly interacts with the residues normally cross-linked by EDC to
prevent intersubunit cross-linking, or (3) changes the conforma-
tion of F-actin so that this zero-length cross-linker no longer spans
the two (or more) residues that are normally cross-linked by EDC.
The ﬁrst explanation is unlikely because no impact of TCTP peptide
on F-actin concentration is evident from the pelleting (Supplemen-
tary Fig. 1C) assays. The second explanation is unlikely because a
peptide that binds directly to residues that are presumably respon-
sible for ionic interactions that hold a ﬁlament together should
have multiple effects on the stability of actin ﬁlaments, and this
was not observed in either effects on F-actin concentration (Sup-
plementary Fig. 1C) or depolymerization assays (not shown). The
third explanation, however, is appealing because TCTP is homolo-
gous to coﬁlin, which does change the twist of an actin ﬁlament
[13]. Multiple reports [13,15,27] provide evidence that only a few
molecules of coﬁlin are sufﬁcient to change the twist of actin ﬁla-
ment, making a structural effect of TCTP peptide on F-actin rele-
vant, even if the afﬁnity is low. Finally, the observation that
intra-ﬁlament trimer increases with TCTP only ﬁts with the third
explanation – a peptide that decreases F-actin or blocks cross-link-
ing should decrease both parallel dimer and trimer. Ultimately,
determination of the physiologic effects of TCTP will require addi-
tional experiments with well-folded, active protein.
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